pfizer Pfizer Seeks Emergency Approval for Highly Effective COVID-19 Vaccine Pfizer officially asks U.S. regulators for emergency use authorization of its COVID-19 vaccine, which shows 95% effectiveness. Limited vaccine supplies could reach Americans by next month.
pfizer Pfizer Seeks Emergency FDA Approval for Highly Effective COVID-19 Vaccine Pfizer and BioNTech officially request emergency use authorization from the FDA for their COVID-19 vaccine after clinical trials show 95% effectiveness. The company states it is ready to begin distributing the vaccine within hours of receiving federal approval.
moderna Moderna Reports 94.5% Efficacy for Its Coronavirus Vaccine Moderna announces that its experimental coronavirus vaccine demonstrates a 94.5% effectiveness rate in preventing COVID-19. The results closely follow similar positive data released by Pfizer last week.
moderna Moderna Reports 94% Effectiveness in COVID-19 Vaccine Trial Moderna reveals its experimental COVID-19 vaccine demonstrates a 94.1% effectiveness rate at preventing illness. The promising results bring a second viable vaccine closer to widespread public distribution.
moderna Moderna Reports High Effectiveness in Late-Stage COVID-19 Vaccine Trial Moderna reveals that its experimental COVID-19 vaccine demonstrates strong effectiveness at preventing the virus. This breakthrough adds a second highly viable candidate to the global pandemic response.
moderna Moderna Covid-19 Vaccine Shows 94.5% Efficacy in Late-Stage Trials Moderna reports that its two-dose coronavirus vaccine demonstrates a 94.5% effectiveness rate in preventing Covid-19. The promising results follow a similar announcement from Pfizer as regulators prepare for fast-tracked emergency approvals.